1-Methyl-4-phenylpyridinium accumulates in cerebellar granule neurons via organic cation transporter 3

Journal of Neurochemistry

Volumn 85, Issue 2, 2003, Pages 358-367

  Shang, Tiesong ^a   Uihlein, Alexander V ^a   Van Asten, Jennifer ^a   Kalyanaraman, Balaraman ^a   Hillard, Cecilia J ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

1 methyl 4 phenyl 1,2,3,6 tetrahydropyridine (MPTP); Beta estradiol; Caspase; Desipramine; GBR 12909; Rotenone

Indexed keywords

1 METHYL 4 PHENYLPYRIDINIUM; CARNITINE; CASPASE 3; CORTICOSTERONE; DESIPRAMINE; DOPAMINE; DOPAMINE TRANSPORTER; ESTRADIOL; MAZINDOL; NORADRENALIN; ORGANIC CATION TRANSPORTER; ORGANIC CATION TRANSPORTER 3; ROTENONE; SEROTONIN; UNCLASSIFIED DRUG; VANOXERINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; CELL CULTURE; CELL DEATH; CEREBELLUM; CONTROLLED STUDY; CULTURE MEDIUM; ENZYME ACTIVATION; FEMALE; GRANULE CELL; IMMUNOCYTOCHEMISTRY; MALE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALIA;

EID: 0344406174     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2003.01686.x     Document Type: Article

References (61)

1. +: evaluations using in vitro and in vivo techniques. Brain Res. 872, 160-171.
2. Bocchetta A., Piccardi M. P., Del Zompo M., Pintus S., and Corsini G. U. (1985) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correspondence of its binding sites to monoamine oxidase in rat brain, and inhibition of dopamine oxidative deamination in vivo and in vitro. J. Neurochem. 45, 673-676.
3. Bums R. S., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitz D. M. and Kopin I. J. (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl Acad. Sci. USA 80, 4546-4550.
4. Callier S., Morissette M., Grandbois M., Pelaprat D. and Di Paolo T. (2001) Neuroprotective properties of 17beta-estradiol, progesterone, and raloxifene in MPTP C57B1/6 mice. Synapse 41, 131-138.
5. +) towards dopaminergic mesencephalic neurones in primary culture. J. Neurochem. 80, 307-316.
6. +) on mitochondrial membrane potential in cerebellar neurons: interaction with the NMDA receptor. J. Neural Transm. 104, 569-577.
7. Chan P., Langston J. W., Irwin I., DeLanney L. E. and Di Monte D. A. (1993) 2-deoxyglucose enhances 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced ATP loss in the mouse brain. J. Neurochem. 61, 610-616.
8. Chen J. Y., Hsu P. C., Hsu I. L., Yeh G. C., Merrill J. E. and Zimmerman R. P. (2001) Sequential up-regulation of the c-fos, c-jun and bax genes in the cortex, striatum and cerebellum induced by a single injection of a low dose of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in C57BL/6 mice. Neurosci. Lett. 314, 49-52.
9. Cheng Y. C. and Prusoff W. H. (1973) Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 percent inhibition (IC50) of an enzymatic reaction. Biochem. Pharmacol. 22, 3099-3110.
10. Chiba K., Trevor A. and Castagnoli N. Jr (1984) Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. Biochem. Biophys. Res. Commun. 120, 574-578.
11. Ciliax B., Heilman C., Demchyshyn L., Pristupa Z., Ince E., Hersch S., Niznik H. and Levey A. (1995) The dopamine transporter: immunochemical characterization and localization in brain. J. Neurosci. 15, 1714-1723.
12. 3H] (+) 3-PPP to sigma receptors in rat brain. Life Sci. 47, PL133-137.
13. Dipasquale B., Marini A. M. and Youle R. J. (1991) Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons. Biochem. Biophys. Res. Commun. 181, 1442-1448.
14. Dluzen D. E. (2000) Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system. J. Neurocytol. 29, 387-399.
15. Du Y., Dodel R. C., Bales K. R., Jemmerson R., Hamilton-Byrd E. and Paul S. M. (1997) Involvement of a caspase-3-like cysteine protease in 1-methyl-4-phenylpyridinium-mediated apoptosis of cultured cerebellar granule neurons. J. Neurochem. 69, 1382-1388.
16. Friedrich A., George R. L., Bridges C. C., Prasad P. D. and Ganapathy V. (2001) Transport of choline and its relationship to the expression of the organic cation transporters in a rat brain microvessel endothelial cell line (RBE4), Biochim. Biophys. Acta 1512, 299-307.
17. + incorporation into cerebellar granule cells. Brain Res. Bull. 56, 119-123.
18. 125I-DEEP. J. Neurosci. 9, 2664-2670.
19. Grundemann D., Gorboulev V., Gambaryan S., Veyhl M., Koepsell H., Merrill J. E. and Zimmerman R. P. (1994) Drug excretion mediated by a new prototype of polyspecific transporter. Nature 372, 549-552.
20. Hallman H., Olson L. and Jonsson G. (1984) Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouse. Eur. J. Pharmacol. 97, 133-136.
21. Hayer-Zillgen M., Bruss M. and Bonisch H. (2002) Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3. Br. J. Pharmacol. 136, 829-836.
22. Heikkila R. E., Cabbat F. S., Manzino L. and Duvoisin R. C. (1984) Effects of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine on neostriatal dopamine in mice. Neuropharmacology 23, 711-713.
23. Hillard C. J., Edgemond W. S., Jarrahian A. and Campbell W. B. (1997) Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J. Neurochem. 69, 631-638.
24. + by dopamine neurons explains selectivity of parkinsonism-inducing neurotoxin, MPTP. Eur J. Pharmacol. 106, 455-456.
25. Javitch J. A., Uhl G. R. and Snyder S. H. (1984) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: characterization and localization of receptor binding sites in rat and human brain. Proc. Natl Acad. Sci. USA 81, 4591-4595.
26. Javitch J. A., D'Amato R. J., Strittmatter S. M. and Snyder S. H. (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc. Natl Acad. Sci. USA 82, 2173-2177.
27. Kekuda R., Prasad P. D., Wu X., Wang H., Fei Y. J., Leibach F. H., Ganapathy V., Merrill J. E. and Zimmerman R. P. (1998) Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta. J. Biol. Chem. 273, 15971-15979.
28. Kilty J. E., Lorang D. and Amara S. G. (1991) Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 254, 578-579.
29. + toxicity and plasma membrane dopamine transporter: study using cell lines expressing the wild-type and mutant rat dopamine transporters. Biochim. Biophys. Acta 1404, 305-313.
30. Kristufek D., Rudorfer W., Pifl C. and Huck S. (2002) Organic cation transporter mRNA and function in the rat superior cervical ganglion. J. Physiol. 543, 117-134.
31. Langston J. W., Forno L. S., Rebert C. S. and Irwin I. (1984a) Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey. Brain Res. 292, 390-394.
32. +): identification of a metabolite of MPTP, a toxin selective to the substantia nigra. Neurosci. Lett. 48, 87-92.
33. Langston J. W., Irwin I., Langston E. B. and Forno L. S. (1984c) Pargyline prevents MPTP-induced parkinsonism in primates. Science 225, 1480-1482.
34. Leist M., Volbracht C., Fava E. and Nicotera P. (1998) 1-Methyl-4-phenylpyridinium induces autocrine excitotoxicity, protease activation, and neuronal apoptosis. J. Pharmacol. Exp. Ther. 54, 789-801.
35. Levinson S. and McCarthy K. (1991) Astroglia in culture, in Culturing Nerve Cells (Banker G. and Goslin K., eds), pp. 311-336. MIT Press, Cambridge.
36. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with Folin phenol reagent. J. Biol. Chem. 193, 265-275.
37. Lucchi R., Notari S., Pierantozzi S., Bamabei O., Villani L. and Poli A. (1998) Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in goldfish cerebellum: neurochemical and immunocytochemical analysis. Brain Res. 782, 105-112.
38. Mariani A. P., Neff N. H. and Hadjiconstantinou M. (1986) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment decreases dopamine and increases lipofuscin in mouse retina. Neurosci. Lett. 72, 221-226.
39. Marini A. M. and Paul S. M. (1992) N-methyl-D-aspartate receptor-mediated neuroprotection in cerebellar granule cells requires new RNA and protein synthesis. Proc. Natl Acad. Sci. USA 89, 6555-6559.
40. Marini A. M., Schwartz J. P. and Kopin I. J. (1989) The neurotoxicity of 1-methyl-4-phenylpyridinium in cultured cerebellar granule cells. J. Neurosci. 9, 3665-3672.
41. Marini A. M., Lipsky R. H., Schwartz J. P. and Kopin I. J. (1992) Accumulation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in cultured cerebellar astrocytes. J. Neurochem. 58, 1250-1258.
42. +) in primary neuron cultures. J. Neurosci. Res. 62, 814-820.
43. Martel F., Ribeiro L., Calhau C., Azevedo I., McGeer E. G. and Stoessl A. J. (1999) Characterization of the efflux of the organic cation MPP+ in cultured rat hepatocytes. Eur J. Pharmacol. 379, 211-218.
44. 1 receptor: pharmacological evidence and therapeutic oppommities. Jpn. J. Pharmacol. 81, 125-155.
45. Miller D. B., Ali S. F., O'Callaghan J. P. and Laws S. C. (1998) The impact of gender and estrogen on striatal dopaminergic neurotoxicity. Ann. N. Y. Acad. Sci. 844, 153-165.
46. O'Callaghan J. P., Seidler F. J., Merrill J. E. and Zimmerman R. P. (1992) 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced astrogliosis does not require activation of omithine decarboxylase. Neurosci. Lett. 148, 105-108.
47. Offen D., Sherki Y., Melamed E., Fridkin M., Brenneman D. E. and Gozes I. (2000) Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease. Brain Res. 854, 257-262.
48. Okuda M., Saito H., Urakami Y., Takano M. and Inui K. (1996) cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2. Biochem. Biophys. Res. Commun. 224, 500-507.
49. Prasad B. M. and Amara S. G. (2001) The dopamine transporter in mesencephalic cultures is refractory to physiological changes in membrane voltage. J. Neurosci. 21, 7561-7567.
50. 3H]pargyline binding to monoamine oxidase. Brain Res. 330, 337-342.
51. Rajan P. D., Kekuda R., Chancy C. D., Huang W., Ganapathy V. and Smith S. B. (2000) Expression of the extraneuronal monoamine transporter in RPE and neural retina. Curr. Eye Res. 20, 195-204.
52. Ricaurte G. A., Langston J. W., DeLanney L. E., Irwin I. and Brooks J. D. (1985) Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum. Neurosci. Lett. 59, 259-264.
53. Shimada S., Kitayama S., Walther D. and Uhl G. (1992) Dopamine transporter mRNA: dense expression in ventral midbrain neurons. Mol. Brain Res. 13, 359-362.
54. 3H]arachidonic acid release from rat neonatal cerebellar granule cells in culture. J. Neurochem. 63, 1311-1318.
55. +) via impairment of energy metabolism. Neurochem. Int. 35, 393-403.
56. Takada M., Campbell K. J. and Hattori T. (1991) Regional localization of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) uptake: mismatch between its uptake and neurotoxic sites. Neurosci. Lett. 133, 137-140.
57. Tomas-Camardiel M., Sanchez-Hidalgo M. C., Sanchez del Pino M. J., Navarro A., Machado A. and Cano J. (2002) Comparative study of the neuroprotective effect of dehydroepiandrosterone and 17beta-estradiol against 1-methyl-4-phenylpyridium toxicity on rat striatum. Neuroscience 109, 569-584.
58. 3H]MPTP binding sites in rat brain. Eur. J. Pharmacol. 98, 453-454.
59. 2) and evidence for the expression of the transporter in the brain. J. Biol. Chem. 273, 32776-32786.
60. Wu X., Huang W., Prasad P. D., Seth P., Rajan D. P., Leibach F. H., Chen J., Conway S. J. and Ganapathy V. (1999) Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/camitine transporter. J. Pharmacol. Exp. Ther 290, 1482-1492.
61. + and not bound metabolites, as the operative neurotoxin. Chem. Res. Toxicol. 1, 228-233.